DFJ Esprit appoints Peter Keen as venture partner
DFJ Esprit has hired Peter Keen as a new venture partner, specialising in medical technology and life science investments.
Keen co-founded Chiroscience Group, after which he helped establish the venture capital firm Merlin Biosciences. On leaving Merlin, he became chief financial officer of pharmaceutical company Arakis.
Keen is currently a non-executive director of Horizon Discovery and Q-Chip, chairman at Oval Medical Technologies, senior independent director at Abcam and a non-executive director of Ark Therapeutics Group and the Biotech Growth Trust.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds








